Caftashell Eye Drops contain Alcaftadine 0.25% w/v, an advanced anti-allergic ophthalmic formulation used to manage itching, redness, and discomfort associated with allergic conjunctivitis. The eye drop offers rapid onset with sustained relief, improving patient comfort during allergy seasons.
Alcaftadine works by blocking histamine receptors and stabilizing mast cells, helping prevent the release of allergy-mediating substances. This dual action supports long-lasting symptom control with convenient once-daily dosing in many cases.
From a business standpoint, Caftashell Eye Drops are a high-rotation ophthalmic product across eye clinics, hospitals, and retail pharmacies. Seasonal demand and repeat usage contribute to consistent prescriptions and steady turnover.
Adding Caftashell Eye Drops to your portfolio strengthens the ophthalmic allergy segment, offering reliable growth, strong prescriber confidence, and long-term market presence for franchise partners.